Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has released a Request for Information (RFI) regarding a new initiative to lower prescription drug costs for Medicare recipients.
美國衛生與公共服務部（HHS）通過醫療保險與醫療補助服務中心（CMS）發佈了有關降低醫療保險接受者處方藥成本的新舉措的信息請求（RFI）。
The Medicare $2 Drug List Model, developed under President Biden's Executive Order 14087, seeks to offer certain generic drugs for a fixed copayment of no more than $2 per month.
根據拜登總統的第14087號行政命令制定的Medicare 2美元藥品清單模型旨在以每月不超過2美元的固定共付額提供某些仿製藥。
This initiative targets commonly prescribed drugs for conditions like high cholesterol and high blood pressure.
該計劃針對的是治療高膽固醇和高血壓等疾病的常用處方藥。
Also Read: Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets.
另請閱讀：諾和諾德的Ozempic可能成爲2027年醫療保險價格談判的目標之一。
The Center for Medicare and Medicaid Innovation (Innovation Center) has designed the Medicare $2 Drug List Model to test whether simplifying access to affordable, clinically important generics will improve health outcomes, improve medication adherence, and boost overall satisfaction with the Medicare Part D program.
醫療保險和醫療補助創新中心（創新中心）設計了Medicare 2美元藥品清單模型，以測試簡化獲得負擔得起的、具有臨床重要性的仿製藥的機會是否會改善健康狀況，提高藥物依從性，並提高對Medicare D部分計劃的總體滿意度。
These drugs, which would not be subject to typical utilization management requirements, could be available at all participating pharmacies as early as January 2027.
這些藥物不受典型使用管理要求的約束，最早可能在2027年1月在所有參與的藥房上市。
The initial list of drugs for the $2 Drug List Model has been carefully developed through a rigorous process. It incorporates input from physicians, pharmacists, and health policy experts to ensure that the selected medications address common conditions for Medicare recipients.
2美元藥品清單模型的初始藥物清單是通過嚴格的程序精心制定的。它納入了醫生、藥劑師和健康政策專家的意見，以確保所選藥物能夠解決醫療保險接受者的常見疾病。
The concept of a fixed-cost drug list is not new, with many retail pharmacies already offering generic medications at low, standardized prices.
固定成本藥品清單的概念並不是什麼新鮮事物，許多零售藥房已經以較低的標準化價格提供仿製藥。
However, the Medicare $2 Drug List Model will be tailored specifically to Medicare recipients.
但是，醫療保險2美元藥品清單模型將專門爲醫療保險接受者量身定製。
Last week, the HHS released final guidance for the second Medicare Drug Price Negotiation Program cycle.
上週，國土安全部發布了第二輪醫療保險藥品價格談判計劃的最終指導方針。
This initiative aims to provide lower drug prices starting in 2026 and 2027.
該計劃旨在從2026年和2027年開始提供更低的藥品價格。
The first round of negotiations focused on ten specific drugs. When the new prices take effect in 2026, Medicare recipients should save approximately $1.5 billion in out-of-pocket costs.
第一輪談判側重於十種特定藥物。當新價格於2026年生效時，醫療保險接受者應節省約15億美元的自付費用。
- Is The iPhone Losing Its Buzz Among Teens? Piper Sandler Finds Out
- iPhone在青少年中失去了知名度嗎？派珀·桑德勒發現了
Image via Shutterstock
圖片來自 Shutterstock
